Jain Laboratory was founded at the University of California San Diego with a mission to innovate mass spectrometry (MS) to enable deeper probing of human biology at population scale. This multi-disciplinary, 25-person team of chemists, engineers, mathematicians, epidemiologists, and physicians developed the next-gen MS systems we use today.
Jain Lab was awarded over $30M in Federal, Foundation, and Industry funding to tackle biological questions across diverse disease areas including heart disease, cancer, lung disease, liver disease, Alzheimer’s, autoimmune disease, vaccine development, maternal fetal health, environmental studies, nutritional studies, and drug response studies.
Sapient was founded by the core Jain Lab members upon seeing the potential of its technologies to transform biomedicine. Now, Sapient is one of the largest capacity biomarker discovery labs in the world.
Sapient was awarded a $9.2M grant from the Bill & Melinda Gates Foundation to support studies aimed at identifying biomarkers that can inform novel nutritional, disease-prevention, and disease-treatment interventions. This grant represented an extension of prior funding awarded to Sapient from the Bill & Melinda Gates Foundation in 2020.
Sapient's high complexity CLIA laboratory received accreditation from the College of American Pathologists (CAP), confirming adherence to stringent CLIA regulations. As a CLIA-certified, CAP-accredited lab, Sapient can support rapid translation of biomarker discoveries to regulated clinical applications, to further accelerate development and deployment of much-needed diagnostics and therapies.
We adhere to the highest regulatory standards, have built a best-in-class team, and ensure quality in every action we take.
We are a team of passionate scientists, clinicians, and engineers, driven by a tireless curiosity to answer the unknowns about human biology.